Wird geladen...

Targeting Multiple Key Signaling Pathways in Melanoma using Leelamine

Melanoma is a highly drug resistant cancer with resistance developing to agents targeting single proteins. To circumvent this problem, a new class of agent inhibiting multiple key pathways important in this disease is being developed to reduce the likelihood of developing resistant disease. The PI3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Cancer Ther
Hauptverfasser: Gowda, Raghavendra, Madhunapantula, SubbaRao V., Kuzu, Omer F., Sharma, Arati, Robertson, Gavin P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377161/
https://ncbi.nlm.nih.gov/pubmed/24688050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0867
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!